{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:03:27Z","timestamp":1784559807906,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmogastro.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Gastrointestinal Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.esmogo.2025.100145","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T16:24:37Z","timestamp":1739809477000},"page":"100145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["An overview of clinical trials in anal cancer 1999-2024"],"prefix":"10.1016","volume":"13","author":[{"given":"D.","family":"Verschoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.S.L.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tardit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Segelov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.esmogo.2025.100145_bib1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/17474124.2020.1775583","article-title":"A 2020 update of anal cancer: the increasing problem in women and expanding treatment landscape","volume":"14","author":"Lum","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100145_bib2","first-page":"924","article-title":"International trends in anal cancer incidence rates","volume":"46","author":"Islami","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"10","key":"10.1016\/j.esmogo.2025.100145_bib3","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/1055-9965.EPI-15-0044","article-title":"Anal cancer incidence in the United States, 1977-2011: distinct patterns by histology and behavior","volume":"24","author":"Shiels","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.esmogo.2025.100145_bib4","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/ijc.34811","article-title":"Trends in epidemiology and primary treatment of anal squamous cell carcinoma in the Netherlands (1990-2021)","volume":"154","author":"Ho","year":"2024","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100145_bib5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ijc.34269","article-title":"Global burden of HPV-attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: a worldwide analysis","volume":"152","author":"Deshmukh","year":"2023","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100145_bib6","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1473-3099(19)30164-1","article-title":"Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis","volume":"19","author":"Lin","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100145_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ijc.33185","article-title":"A meta-analysis of anal cancer incidence by risk group: toward a unified anal cancer risk scale","volume":"148","author":"Clifford","year":"2021","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100145_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/cid\/ciad205","article-title":"Human papillomavirus-associated anal cancer incidence and burden among US Men, according to sexual orientation, human immunodeficiency virus status, and age","volume":"77","author":"Deshmukh","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100145_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25110","article-title":"Evidence of synergistic relationships between HIV and human papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status","volume":"21","author":"Looker","year":"2018","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100145_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/QAD.0000000000002059","article-title":"Increased risk of anal squamous cell carcinoma in HIV-positive men with prior hepatitis B virus infection","volume":"33","author":"Aldersley","year":"2019","journal-title":"AIDS"},{"issue":"10","key":"10.1016\/j.esmogo.2025.100145_bib11","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/jnci\/djad128","article-title":"Cumulative incidence of anal cancer since HIV or AIDS diagnosis in the United States","volume":"115","author":"Haas","year":"2023","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100145_bib12","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/QAD.0000000000002218","article-title":"Incidence and time trends of anal cancer among people living with HIV in Australia","volume":"33","author":"Jin","year":"2019","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.esmogo.2025.100145_bib13","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1111\/ajt.15942","article-title":"Burden of anal squamous cell carcinoma, squamous intraepithelial lesions and HPV16 infection in solid organ transplant recipients: a systematic review and meta-analysis","volume":"20","author":"Albuquerque","year":"2020","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100145_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41416-018-0273-9","article-title":"Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis","volume":"120","author":"Gilbert","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.esmogo.2025.100145_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jnci\/djad214","article-title":"Human papillomavirus associated anal squamous cell carcinoma: sociodemographic, geographic, and county-level economic trends in incidence rates-United States, 2001-2019","volume":"116","author":"Gopalani","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.esmogo.2025.100145_bib16","doi-asserted-by":"crossref","first-page":"e1186","DOI":"10.1097\/DCR.0000000000002940","article-title":"Incidence of anal cancer and related risk factors in HIV-infected patients enrolled in the National Prospective Spanish Cohort CoRIS","volume":"66","author":"Sendagorta Cud\u00f3s","year":"2023","journal-title":"Dis Colon Rectum"},{"issue":"10","key":"10.1016\/j.esmogo.2025.100145_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205105","article-title":"Anal cancer in high-income countries: increasing burden of disease","volume":"13","author":"Kang","year":"2018","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.esmogo.2025.100145_bib18","doi-asserted-by":"crossref","first-page":"852","DOI":"10.6004\/jnccn.2018.0060","article-title":"Anal carcinoma, version 2.2018, NCCN Clinical Practice Guidelines in oncology","volume":"16","author":"Benson","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"10.1016\/j.esmogo.2025.100145_bib19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ejso.2014.07.030","article-title":"Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"40","author":"Glynne-Jones","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100145_bib20","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.annonc.2021.06.015","article-title":"Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Rao","year":"2021","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.esmogo.2025.100145_bib21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/BF02553933","article-title":"An evaluation of combined therapy for squamous cell cancer of the anal canal","volume":"27","author":"Nigro","year":"1984","journal-title":"Dis Colon Rectum"},{"issue":"22","key":"10.1016\/j.esmogo.2025.100145_bib22","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1200\/JCO.19.03266","article-title":"International rare cancers initiative multicenter randomized phase II trial of cisplatin and fluorouracil versus carboplatin and paclitaxel in advanced anal cancer: InterAAct","volume":"38","author":"Rao","year":"2020","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.esmogo.2025.100145_bib23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/0284186X.2022.2048069","article-title":"Anal cancer in Sweden 2015-2019. Implementation of guidelines, structural changes, national registry and early results","volume":"61","author":"Johnsson","year":"2022","journal-title":"Acta Oncol"},{"key":"10.1016\/j.esmogo.2025.100145_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109542","article-title":"Treatment, outcome, and prognostic factors in non-metastatic anal cancer: the French nationwide cohort study FFCD-ANABASE","volume":"183","author":"Vendrely","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.esmogo.2025.100145_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2022.102099","article-title":"Trends in incidence and survival from anal cancer and incidence of high-grade anal intraepithelial neoplasia in Denmark","volume":"77","author":"Urbute","year":"2022","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100145_bib26","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/S2352-3018(23)00257-6","article-title":"Survival by sex and HIV status in patients with anal cancer in the USA between 2001 and 2019: a retrospective cohort study","volume":"11","author":"Shing","year":"2024","journal-title":"Lancet HIV"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100145_bib27","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s12029-020-00472-2","article-title":"Racial\/ethnic disparities in survival among women diagnosed with invasive cancer of the anal canal: an analysis of surveillance, epidemiology, and end results (SEER) data","volume":"52","author":"Stenzel","year":"2021","journal-title":"J Gastrointest Cancer"},{"issue":"4","key":"10.1016\/j.esmogo.2025.100145_bib28","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/CCO.0000000000000748","article-title":"Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trials","volume":"33","author":"Giunta","year":"2021","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100145_bib29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13027-020-00332-5","article-title":"Prognostic implication of human papillomavirus types in cervical cancer patients: a systematic review and meta-analysis","volume":"15","author":"Xu","year":"2020","journal-title":"Infect Agent Cancer"},{"issue":"24","key":"10.1016\/j.esmogo.2025.100145_bib30","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2201048","article-title":"Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer","volume":"386","author":"Palefsky","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.esmogo.2025.100145_bib33","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jamaoncol.2021.0379","article-title":"Evolution of the randomized clinical trial in the era of precision oncology","volume":"7","author":"Del","year":"2021","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100145_bib34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamaoncol.2020.7478","article-title":"An analysis of contemporary oncology randomized clinical trials From low\/middle-income vs high-income countries","volume":"7","author":"Wells","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.esmogo.2025.100145_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106399","article-title":"HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019","volume":"144","author":"Bruni","year":"2021","journal-title":"Prev Med"},{"key":"10.1016\/j.esmogo.2025.100145_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100836","article-title":"Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis","volume":"34","author":"Dorji","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.esmogo.2025.100145_bib37","first-page":"1","article-title":"Global availability of cancer registry data","volume":"4","author":"Siddiqui","year":"2018","journal-title":"J Glob Oncol"},{"issue":"4","key":"10.1016\/j.esmogo.2025.100145_bib38","first-page":"279","article-title":"Treatment of squamous cell carcinoma of the anus, unresolved areas and future perspectives for research: perspectives of research needs in anal cancer","volume":"20","author":"Guren","year":"2021","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.esmogo.2025.100145_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068791","article-title":"Searching clinical trials registers: guide for systematic reviewers","volume":"377","author":"Hunter","year":"2022","journal-title":"Br Med J"}],"container-title":["ESMO Gastrointestinal Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819825000147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819825000147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:29:25Z","timestamp":1784557765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949819825000147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"alternative-id":["S2949819825000147"],"URL":"https:\/\/doi.org\/10.1016\/j.esmogo.2025.100145","relation":{},"ISSN":["2949-8198"],"issn-type":[{"value":"2949-8198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An overview of clinical trials in anal cancer 1999-2024","name":"articletitle","label":"Article Title"},{"value":"ESMO Gastrointestinal Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmogo.2025.100145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100145"}}